1-3 of 3
Celine Chapelle
Close
Sort by
Journal Articles

Efficacy and Safety Outcomes in Patients with Cancer-Associated Thromboembolism Treated with Tinzaparin According to the Tumor Site: Meta-Analysis of Prospective Studies Involving 1413 Individual Patients' Data

Isabelle Mahe, Céline Chapelle, Luis Jara-Palomares, Olivier Sanchez, Philippe Girard, Guy Meyer, Agnes Yuet Ying Lee, Géraldine Poénou, Silvy Laporte
Journal: Blood
Blood (2023) 142 (Supplement 1): 2646.
https://doi.org/10.1182/blood-2023-177979
Published: 2023
Journal Articles

Use of Anticoagulants of Patients with Cancer-Associated Thrombosis Beyond 6 Months ; The Uscat Study, a 432-Patient Retrospective Non-Interventional Study

Isabelle Mahe, MD PhD, Ludovic Plaisance, MD, Céline Chapelle, Silvy Laporte, MS, PhD, Benjamin Planquette, MD PhD, Laurent Bertoletti, MD PhD, Jean Chidiac, MD, Francis Couturaud, MD PhD, Lionel Falchiero, MD, Nicolas Falvo, MD, Isild Mahé, Hélène Helfer, PhD, Guy Meyer
Journal: Blood
Blood (2019) 134 (Supplement_1): 3664.
https://doi.org/10.1182/blood-2019-124745
Published: 2019
Journal Articles

Validation of the Ottawa Score in Cancer Patients with Venous Thromboembolism. the Predicare Cohort Study

Guy Meyer, Celine Chapelle, Philippe Girard, MD, Florian Scotté, MD PhD, Anne Lamblin, Silvy Laporte, MS, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 167.
https://doi.org/10.1182/blood-2019-129087
Published: 2019